Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice
Beijing Institute of Pharmacology and Toxicology, Beijing, China
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China
Article notes
Untitled section
Received 2017 Nov 8; Accepted 2017 Nov 20; Collection date 2017.
Untitled section
Keywords: CB1R antagonist, obesity, periphery, blood–brain-barrier
There is an error in the Funding statement. The correct number for the Major Program of the Ministry of Science and Technology of China is 2012ZX09301-001, 2012ZX09301-003.
In the original article, we neglected to include the funder the National Natural Science Foundation of China, 81430090 to LW.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.